Cephalexin Oral Suspension Recalled for Failed Impurities Specifications
Ascend Laboratories is recalling Cephalexin for Oral Suspension due to an out-of-specification result in impurity testing that identified Cephalexin Glucose Adduct during stability analysis.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The source documents an FDA Class II recall with an out-of-specification impurity finding detected during stability testing. No illnesses, hospitalizations, or injuries are reported, making this a precautionary quality issue without evidence of actual patient harm.
Plain-English summary
Ascend Laboratories, LLC is recalling Cephalexin for Oral Suspension, USP, 125 mg per 5 mL (200 mL bottles) distributed nationwide in the USA. The recall was initiated because an out-of-specification result was observed in the related substance test at the sixth month of stability analysis. The individual impurity identified was Cephalexin Glucose Adduct.
The affected product is manufactured by Alkem Laboratories Ltd., India, and distributed by Ascend Laboratories, LLC, Parsippany, NJ 07054. Affected lot numbers include: 23142343 (Exp Date 6/30/2025), 23143526 (Exp Date 9/30/2025), 23144036 (Exp Date 10/31/2025), 23144269 (Exp Date 11/30/2025), 24140027 (Exp Date 12/31/2025), and 24144282 (Exp Date 10/31/2026), with NDC 67877-544-68.
Patients who have this medication should consult their healthcare provider or pharmacist about whether to continue use or obtain a replacement. Healthcare providers should contact the recalling firm for additional information.
The recalled product
- Product
- CEPHALEXIN (CEPHALEXIN)
- Brand
- CEPHALEXIN
- Manufacturer
- Ascend Laboratories, LLC
- Category
- Drug — Oral Suspension
- Hazard
- impurity-specification
- degradation-product
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (12)
- Lot #: 23142343
- Exp Date: 6/30/2025
- 23143526
- Exp Date: 9/30/2025
- 23144036
- Exp Date: 10/31/2025
- 23144269
- Exp Date: 11/30/2025
- Lot 24140027
- Exp Date: 12/31/2025
- 24144282
- Exp Date: 10/31/2026
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · CEPHALEXIN
- ModerateCephalexin Oral Suspension Recalled for Failed Impurity Specifications
FDA (Drugs) · 2025-06-18
- ModerateCephalexin oral suspension recalled for incorrect label dosage amount
FDA (Drugs) · 2024-06-12
- LowCephalexin Oral Suspension Recalled for Incorrect Labeling and Missing Dosage Information
FDA (Drugs) · 2024-06-12
- ModerateCephalexin oral suspension recalled for incorrect dose labeling
FDA (Drugs) · 2024-06-12
- ModerateCephalexin Oral Suspension Recalled for Incorrect Dosage Label
FDA (Drugs) · 2024-06-12
Same category
- ModerateQuality Choice Earwax Removal Kit Carbamide Peroxide Subpotent Drug Recall
FDA (Drugs) · 2026-07-22
- ModerateLeader Carbamide Peroxide Earwax Removal Kit Recalled for Subpotency
FDA (Drugs) · 2026-07-22
- SevereCleviprex Injectable Emulsion Recall Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-07-22
- ModerateFamily Wellness Carbamide Peroxide Earwax Removal Kit Subpotent Drug
FDA (Drugs) · 2026-07-22
- ModerateClinere Ear Wax Remover Recalled for Subpotent Carbamide Peroxide
FDA (Drugs) · 2026-07-22